CapsoVision, Inc. (CV)
NASDAQ: CV · Real-Time Price · USD
6.70
+0.37 (5.85%)
Sep 18, 2026, 4:00 PM EDT - Market closed
CapsoVision Employees
CapsoVision had 99 employees as of December 31, 2025. The number of employees increased by 9 or 10.00% compared to the previous year.
Employees
99
Change
9
Growth
10.00%
Revenue / Employee
$140,313
Profits / Employee
-$301,303
Market Cap
335.31M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 99 | 9 | 10.00% |
| Mar 31, 2025 | 90 | - | - |
| Dec 31, 2024 | 90 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Orthofix Medical | 1,605 |
| Viemed Healthcare | 1,438 |
| Pacific Biosciences of California | 485 |
| Treace Medical Concepts | 450 |
| Standard BioTools | 389 |
| AVITA Medical | 226 |
| ClearPoint Neuro | 172 |
| Perspective Therapeutics | 166 |
CV News
- 17 days ago - CapsoVision to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 23 days ago - CapsoVision resumed with a Buy at Roth Capital - TheFly
- 24 days ago - Outlook CFO Lawrence Kenyon to step down, Kevin Lundquist to succeed - TheFly
- 25 days ago - CapsoVision initiated with a Buy at Titan Partners - TheFly
- 5 weeks ago - CapsoVision files $250M mixed securities shelf - TheFly
- 5 weeks ago - CapsoVision Earnings Call Transcript: Q2 2026 - Transcripts
- 5 weeks ago - CapsoVision Earnings release: Q2 2026 - Filings
- 5 weeks ago - CapsoVision Quarterly report: Q2 2026 - Filings